Jianmin Pharmaceutical Group Co Ltd
SSE:600976
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Jianmin Pharmaceutical Group Co Ltd
Income to Minority Interest
Jianmin Pharmaceutical Group Co Ltd
Income to Minority Interest Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income to Minority Interest | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Jianmin Pharmaceutical Group Co Ltd
SSE:600976
|
Income to Minority Interest
-¥5.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-38%
|
CAGR 10-Years
-38%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Income to Minority Interest
-¥2.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
25%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Income to Minority Interest
-¥36.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Income to Minority Interest
-¥37.9m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Jianmin Pharmaceutical Group Co Ltd
Glance View
Jianmin Pharmaceutical Group Co., Ltd. engages in the research, development, manufacturing, wholesale and retail of pharmaceutical products. The company is headquartered in Wuhan, Hubei and currently employs 2,004 full-time employees. The company went IPO on 2004-04-19. The firm operates its businesses through two segments, including Pharmaceutical Industry and Pharmaceutical Business. The Pharmaceutical Industry segment is engaged in the research and development and manufacture of pharmaceuticals. Its products are mainly applied in children, women and the elderly, among others. The Pharmaceutical Business segment is engaged in the wholesale and retailing of pharmaceuticals. Its products include traditional Chinese medicine, Western medicine, health products, medical equipment and chemical agents. The company distributes its products mainly in domestic market.
See Also
What is Jianmin Pharmaceutical Group Co Ltd's Income to Minority Interest?
Income to Minority Interest
-5.1m
CNY
Based on the financial report for Mar 31, 2026, Jianmin Pharmaceutical Group Co Ltd's Income to Minority Interest amounts to -5.1m CNY.
What is Jianmin Pharmaceutical Group Co Ltd's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 10Y
-38%
Over the last year, the Income to Minority Interest growth was 12%.
